Vaccination

In the aftermath of Hurricanes Irma and Maria, which struck the Caribbean in September 2017, the American Society of Nephrology was asked to provide logistical support to kidney care providers and patients with kidney diseases.

Nearly 80% of infants born in a California health system were exposed to nirsevimab or the maternal respiratory syncytial virus vaccine in 2023-2024, the first season in which they were available, according to study findings.

Short-term apnea is more common among hospitalized preterm infants who receive their 2-month vaccines compared with those who do not, according to the results of a randomized clinical trial published in JAMA Pediatrics.

In early December, health officials in the Democratic Republic of the Congo, or DRC, announced that an unknown illness had emerged and had already killed dozens of patients, with hundreds more sick.

A suspected Marburg virus outbreak in Tanzania has been linked to nine cases and eight deaths, according to WHO.

Nearly one in six U.S. children received at least one vaccine dose outside the recommended age guidelines during a recent 10-year period, according to study findings published in Pediatrics.

Throughout 2024, data surrounding STDs came in waves of good and bad news, with data showing slower rates of infection and even disease elimination intermingling with news of hospitals failing to follow CDC guidance.

Data from a postlicensure study support the CDC’s recommendation that Heplisav-B can now be administered to pregnant persons needing hepatitis B vaccination, as its use did not appear to increase risk for major birth defects or miscarriage.

Each month, we ask one of our PharmD columnists to dig into the literature to find evidence-based answers to important clinical questions in the field of infectious diseases.

The bivalent respiratory syncytial virus prefusion F, or RSVpreF, vaccine may prevent one hospitalization or ED visit tied to the infection for every 250 vaccinated older adults, an analysis showed.